A UK vision for life science SMEs - but will it cut the mustard with government?
This article was originally published in Clinica
The voice of life science companies was echoing around the UK last month in response to a call from the industry to tell the government what they need to help them succeed.
You may also be interested in...
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.